NCT02242461

Rhodiola Crenulata as an Adjunctive Therapy in COPD

Rhodiola Crenulata as an Adjunctive Therapy in Patients With Chronic Obstructive Pulmonary Disease

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 57 (actual)
• Sponsor: Chung Shan Medical University · Academic / Other
• Sex: All
• Age: 40 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

We hypothesize that add-on Rhodiola L extract capsule to the regimen of patients with moderate-to-severe COPD (1) may provide a potential of systemic effects of anti-inflammation and anti-oxidation for these patients, and these effects (2) may reflect in the improvement of patients' physiological measurements, quality of life and exercise tolerance.

Detailed description

This is a single center, randomized, double-blind, placebo controlled clinical trial. Eligibility criteria: 1. moderate-to-severe COPD patients 2. aged 40-80 years, 3. abstaining from cigarette smoking or maintaining a stable dose of cigarette consumption, 4. no acute exacerbation of COPD, 5. clinically being stable for one month and longer, 6. not undergoing exercise training program. Primary endpoint: six-minute walk distance in meters at week 12.

Conditions

• COPD

Interventions

Type	Name	Description
DRUG	Rhodiola placebo capsules	Corn starch
DRUG	Rhodiola Crenulata	Rhodiola Crenulata

Timeline

• Start date: 2012-05-01
• Primary completion: 2013-07-01
• Completion: 2013-07-01
• First posted: 2014-09-17
• Last updated: 2014-09-17

Locations

1 site across 1 country: Taiwan